Analysts Suggest MegaIPOs From SpaceX and OpenAI May Signal Market Peak as Record Listings Loom Trumps Mixed Signals on Iran Deal Keep Oil Markets on Edge as Summer Stockpile Risks Loom IFB Industries Q4 Net Profit Doubles to Rs 4267 Crore Revenue Up 1233 Inflation Rate Could Reach 6 in Q2 According to Economic Forecasters Stocks Edge Higher as Healthcare and Tech Rally Communication Services Lag Huawei Unveils New Chip Design Approach Plans Fall Smartphone Chip Launch LSF Q1 2026 Earnings Stunning EPS Beat Defies Expectations Stock Slips SU Q1 2026 Earnings Strong EPS Beat Highlights Operational Efficiency Amid Market Challenges Nexstar Media Group NXST Q1 2026 Earnings EPS Beats Estimates by Over 13 Despite Flat Revenue Outlook FE Q1 2026 Earnings EPS Misses Estimates Amidst Operational Challenges Stock Holds Steady OS Therapies OSTX Q4 2025 Earnings WiderThanExpected Loss Weighs on Shares FULTP Q1 2026 Earnings Fractional EPS Beat Signals Stable Preferred Dividend Coverage Morgan Stanley MS Edges Higher as Price Nears Key Resistance Levels Investors Title Company ITIC Edges Lower Amid Consolidation Near 240 Resistance Zone TechTarget TTGT Slides 23 as Stock Tests Key Support Level Veeva Systems VEEV Edges Lower in Quiet Trading Support and Resistance Levels in Focus Sylvamo Corporation SLVM Rallies Toward Resistance Amid Volume Shift Endurance Technologies IPO Opens Key Details and Market Implications ESLT Q4 2025 Earnings EPS Surges Past Estimates on Robust Defense Orders News Corporation NWS Edges Higher as Turnaround Momentum Building Stock Nears Resistance TDG Q1 2026 Earnings Strong EPS Beat Highlights Resilient Aerospace Demand LOMA Q1 2026 Earnings Strong EPS of 3505 Despite Negative Stock Reaction CVCO Q1 2026 Earnings EPS Beats Estimates Amid Solid Housing Demand STWD Q1 2026 Earnings EPS Misses Estimates Amid Challenging CRE Environment TME Q1 2026 Earnings Slightly Beats Estimates as Shares Rise 45 HBAN Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher NVCT Q1 2026 Earnings Narrower Loss Beats Estimates as Clinical Pipeline Advances